Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis

Key Points. Single-agent bortezomib produces durable hematologic responses and promising long-term overall survival in relapsed AL patients.Once-weekly bortezo

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reece, Donna E. (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Sanchorawala, Vaishali (VerfasserIn) , Merlini, Giampaolo (VerfasserIn) , Palladini, Giovanni (VerfasserIn) , Bladé, Joan (VerfasserIn) , Fermand, Jean-Paul (VerfasserIn) , Hassoun, Hani (VerfasserIn) , Heffner, Leonard (VerfasserIn) , Kukreti, Vishal (VerfasserIn) , Vescio, Robert A. (VerfasserIn) , Pei, Lixia (VerfasserIn) , Enny, Christopher (VerfasserIn) , Esseltine, Dixie-Lee (VerfasserIn) , van de Velde, Helgi (VerfasserIn) , Cakana, Andrew (VerfasserIn) , Comenzo, Raymond L. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 8, 2014
In: Blood
Year: 2014, Jahrgang: 124, Heft: 16, Pages: 2498-2506
ISSN:1528-0020
DOI:10.1182/blood-2014-04-568329
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2014-04-568329
Verlag, lizenzpflichtig, Volltext: https://ashpublications.org/blood/article/124/16/2498/33209/Long-term-follow-up-from-a-phase-1-2-study-of
Volltext
Verfasserangaben:Donna E. Reece, Ute Hegenbart, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Joan Bladé, Jean-Paul Fermand, Hani Hassoun, Leonard Heffner, Vishal Kukreti, Robert A. Vescio, Lixia Pei, Christopher Enny, Dixie-Lee Esseltine, Helgi van de Velde, Andrew Cakana, and Raymond L. Comenzo

MARC

LEADER 00000caa a2200000 c 4500
001 1703774795
003 DE-627
005 20220818142435.0
007 cr uuu---uuuuu
008 200706s2014 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2014-04-568329  |2 doi 
035 |a (DE-627)1703774795 
035 |a (DE-599)KXP1703774795 
035 |a (OCoLC)1341344425 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Reece, Donna E.  |e VerfasserIn  |0 (DE-588)1213265681  |0 (DE-627)1703775570  |4 aut 
245 1 0 |a Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis  |c Donna E. Reece, Ute Hegenbart, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Joan Bladé, Jean-Paul Fermand, Hani Hassoun, Leonard Heffner, Vishal Kukreti, Robert A. Vescio, Lixia Pei, Christopher Enny, Dixie-Lee Esseltine, Helgi van de Velde, Andrew Cakana, and Raymond L. Comenzo 
264 1 |c September 8, 2014 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.07.2020 
520 |a Key Points. Single-agent bortezomib produces durable hematologic responses and promising long-term overall survival in relapsed AL patients.Once-weekly bortezo 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Sanchorawala, Vaishali  |e VerfasserIn  |4 aut 
700 1 |a Merlini, Giampaolo  |e VerfasserIn  |4 aut 
700 1 |a Palladini, Giovanni  |e VerfasserIn  |4 aut 
700 1 |a Bladé, Joan  |e VerfasserIn  |4 aut 
700 1 |a Fermand, Jean-Paul  |e VerfasserIn  |4 aut 
700 1 |a Hassoun, Hani  |e VerfasserIn  |4 aut 
700 1 |a Heffner, Leonard  |e VerfasserIn  |4 aut 
700 1 |a Kukreti, Vishal  |e VerfasserIn  |4 aut 
700 1 |a Vescio, Robert A.  |e VerfasserIn  |4 aut 
700 1 |a Pei, Lixia  |e VerfasserIn  |4 aut 
700 1 |a Enny, Christopher  |e VerfasserIn  |4 aut 
700 1 |a Esseltine, Dixie-Lee  |e VerfasserIn  |4 aut 
700 1 |a van de Velde, Helgi  |e VerfasserIn  |4 aut 
700 1 |a Cakana, Andrew  |e VerfasserIn  |4 aut 
700 1 |a Comenzo, Raymond L.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 124(2014), 16, Seite 2498-2506  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis 
773 1 8 |g volume:124  |g year:2014  |g number:16  |g pages:2498-2506  |g extent:9  |a Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis 
856 4 0 |u https://doi.org/10.1182/blood-2014-04-568329  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ashpublications.org/blood/article/124/16/2498/33209/Long-term-follow-up-from-a-phase-1-2-study-of  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200706 
993 |a Article 
994 |a 2014 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1703774795  |e 3695880767 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Donna E. Reece, Ute Hegenbart, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Joan Bladé, Jean-Paul Fermand, Hani Hassoun, Leonard Heffner, Vishal Kukreti, Robert A. Vescio, Lixia Pei, Christopher Enny, Dixie-Lee Esseltine, Helgi van de Velde, Andrew Cakana, and Raymond L. Comenzo"]},"person":[{"display":"Reece, Donna E.","role":"aut","given":"Donna E.","family":"Reece"},{"display":"Hegenbart, Ute","given":"Ute","role":"aut","family":"Hegenbart"},{"family":"Sanchorawala","display":"Sanchorawala, Vaishali","given":"Vaishali","role":"aut"},{"family":"Merlini","given":"Giampaolo","role":"aut","display":"Merlini, Giampaolo"},{"family":"Palladini","given":"Giovanni","role":"aut","display":"Palladini, Giovanni"},{"family":"Bladé","role":"aut","given":"Joan","display":"Bladé, Joan"},{"display":"Fermand, Jean-Paul","role":"aut","given":"Jean-Paul","family":"Fermand"},{"family":"Hassoun","display":"Hassoun, Hani","role":"aut","given":"Hani"},{"display":"Heffner, Leonard","given":"Leonard","role":"aut","family":"Heffner"},{"family":"Kukreti","display":"Kukreti, Vishal","role":"aut","given":"Vishal"},{"family":"Vescio","role":"aut","given":"Robert A.","display":"Vescio, Robert A."},{"display":"Pei, Lixia","role":"aut","given":"Lixia","family":"Pei"},{"display":"Enny, Christopher","given":"Christopher","role":"aut","family":"Enny"},{"given":"Dixie-Lee","role":"aut","display":"Esseltine, Dixie-Lee","family":"Esseltine"},{"display":"van de Velde, Helgi","given":"Helgi","role":"aut","family":"van de Velde"},{"display":"Cakana, Andrew","given":"Andrew","role":"aut","family":"Cakana"},{"display":"Comenzo, Raymond L.","role":"aut","given":"Raymond L.","family":"Comenzo"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"September 8, 2014"}],"recId":"1703774795","physDesc":[{"extent":"9 S."}],"id":{"doi":["10.1182/blood-2014-04-568329"],"eki":["1703774795"]},"relHost":[{"titleAlt":[{"title":"Blood online"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266886647","origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946"}],"corporate":[{"role":"isb","display":"American Society of Hematology"}],"note":["Gesehen am 21.04.2023"],"disp":"Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosisBlood","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1468538-3"],"issn":["1528-0020"],"eki":["266886647"]},"pubHistory":["1.1946 -"],"part":{"year":"2014","text":"124(2014), 16, Seite 2498-2506","volume":"124","pages":"2498-2506","extent":"9","issue":"16"},"language":["eng"],"title":[{"title_sort":"Blood","subtitle":"journal of the American Society of Hematology","title":"Blood"}]}],"note":["Gesehen am 06.07.2020"],"title":[{"title":"Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis","title_sort":"Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis"}],"language":["eng"]} 
SRT |a REECEDONNALONGTERMFO8201